stock listing
Centogene Gets Nasdaq Non-Compliance Notice
The company has 180 days from the date of the notice to regain compliance with the listing requirement, during which time it will continue to trade on the exchange.
T2 Biosystems Regains Compliance with Nasdaq Listing Requirement
The company had previously been informed that its shares failed to meet the exchange's $1 minimum bid price requirement.
DiaCarta to go Public Through SPAC Merger
The firm would join a number of biopharma and diagnostic companies that have used SPACs during the COVID-19 pandemic to tap the public markets.
AnPac Bio Receives Nasdaq Delisting Determination
The firm plans to appeal the decision, which comes after Nasdaq warned AnPac it did not meet a minimum $1 per share bid price requirement.
T2 Biosystems Regains Nasdaq Listing Requirements
The Massachusetts-based company's minimum market value of listed securities rebounded above $35 million in August, meeting listing requirements.